Stock & Company Details
Ascendis Pharma A/S Ordinary Share $ASND
Price:
46,691,331
$17B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
ASND technical indicators
Latest Ascendis Pharma A/S Ordinary Share (ASND) technical indicators as of 2026-07-14: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
60.29 0.4%
MACD:
10.89 6.3%
SMA 50:
$239.97 0.3%
SMA 200:
—
EMA 20:
$257.36 0.3%
Bollinger Bands:
291 / 219
Stochastic:
72.07 10.1%
ADX 14:
32.48 1.0%
ATR 14:
9.40 3.6%
CCI 20:
44.37 2.3%
OBV:
-7.95M 6.0%
ROC 12:
1.53% 86.7%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Finance Bot
Ask your questions
Start by typing a question below.
